Multinucleate cell angiohistiocytoma is a rare, vascular, fibrohistiocytic proliferation that has a benign but progressive course. The clinical presentation is that of grouped red-purple papules and nodules characteristically located on the lower extremities in women. The histopathology shows a proliferation of narrow vessels within thickened collagen bundles associated with multinucleate giant cells. These lesions are probably reactive in nature, and several mechanisms of pathogenesis, including hormonal, have been proposed. Different modalities, including intense pulsed light and pulsed-dye laser, have been used for treatment of these lesions. We report a case of a 74-year-old Caucasian woman with long-standing multinucleate angiohistiocytoma on her bilateral thighs that eluded diagnosis for several years. Upon biopsy and histopathological analysis, the diagnosis was made. Treatment options were entertained, although ultimately not pursued by the patient. We report this case to increase clinical awareness of this rare disease and to contribute to the ongoing literature aimed to further characterize this condition. 
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| DISCUSSION
MCAH is an uncommon vascular fibrohistiocytic proliferation that often presents as grouped red-purple papules and nodules. [1] [2] [3] Lesions typically arise on the dorsal hands and lower extremities. 4 Localized, multifocal, and generalized variants have been reported; the localized variant is most common and best-described. 1, 5 There is an overwhelming female predilection for localized and multifocal lesions; on the other hand, the generalized variant shows no significant gender tendency. 1, 5 Since the first description of MCAH in 1985, multiple hypotheses regarding etiology and pathogenesis have been proposed. 6 It is generally favored that these lesions arise as a reactive rather than a neoplastic process. 1, 5 Several reports of spontaneous remission further support the reactive hypothesis. 7 Another theory proposes that MCAH arises secondary to female hormone influence, noting the identification of ER alpha expression on the interstitial and multinucleate cells of the lesions. 8 This theory also serves to explain why MCAH occurs more frequently in women, with a ratio of 3:1 female to male. 4 FIGURE 2 (H&E, ×100) proliferation of poorly grouped capillaries and small venules within a collagenous fibrotic stroma in the superficial and mid dermis FIGURE 3 (H&E, ×200) groups of capillaries and venules with scattered multinucleate giant cells in the superficial and mid dermis FIGURE 4 (H&E, ×400) high-power view demonstrating the unique multinucleate cells (yellow arrows) scattered throughout the proliferation of vessels discussion considers whether MCAH may represent a variant of dermatofibroma. These two entities were directly compared and contrasted in an article by Doshi-Chougule et al, 10 sparking further debate over the pathogenesis of MCAH and its existence as an independent diagnosis. In this article, significant overlap in the histopathologic characteristics of MCAH and dermatofibroma were described. However, the clinical presentation of dermatofibroma as a flesh-colored dimpling firm papule differs from MCAH, which is characterized by grouped redbrown papules and plaques. This may be enough to allow for distinction between these two entities. Expression of CD68 can also be variably positive or sometimes negative in the multinucleate giant cells. 1, 4, 9 The course of multinucleate angiohistiocytoma tends to be progressive but benign. 1, 4 Treatment is not required, but may be desired by patients for cosmetic reasons. Although no standard of care exists, lesions may be treated with topical or intralesional corticosteroids prior to more aggressive measures. Surgical excision, cryotherapy, pulsed-dye laser, argon laser, intense pulsed light, and carbon dioxide laser can also be considered and have all shown anecdotal efficacy. 2, 4, 12 The rationale behind the use of intense pulsed light and pulsed-dye laser is based on the vascular oxyhemoglobin targets notable in MCAH, and both modalities offer desirable non-ablative approaches to interventional therapy. 12, 13 Additional studies may also be helpful in discovering newer treatment modalities that might achieve more consistent and long-term remission.
| CONCLUSION
Our patient presented with grouped red papules and plaques that were biopsied and found to be diagnostic of MCAH. This rare entity, of unknown etiology and pathogenesis, is benign but progressive, and may be a cosmetic nuisance for patients. The hypothesis that MCAH may develop in response to female hormone influence remains interesting, considering that our patient had a history of ovarian cancer. However, a temporal relationship between the development of skin lesions and the ovarian malignancy could not be confirmed; furthermore, negative hormone receptor immunohistochemical staining did not seem to support this theory in our patient. If future studies determine that there is indeed a hormonal association, this may lead to a better understanding of the etiology of MCAH as well as additional therapeutic modalities.
Further studies are required to delineate the etiology of MCAH and origin of the multinucleate cells that comprise these lesions.
Treatment options are available to improve the cosmetic outcome, although most are supported only by case reports and anecdotal evidence. Our patient chose not to pursue further treatment because of co-morbidities, but should she request treatment in the future therapeutic pulsed-dye laser would probably be considered.
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